---
schema_version: "secwatch.filing_event.v1"
accession: "0001933414-23-000024"
form_type: "8-K"
ticker: "MLYS"
cik: "0001933414"
company_name: "Mineralys Therapeutics, Inc."
filed_at: "2023-03-22T23:59:59+00:00"
generated_at: "2026-06-17T21:45:43.248479+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Mineralys Therapeutics discloses 2022 executive bonuses and raises 2023 target bonus percentages

## Summary
- 2022 bonuses: CEO Congleton $193.2k, CFO Levy $190.9k, CMO Rodman $190.8k.
- 2023 target bonuses increased: Congleton 50% of base salary, Rodman 45%, Levy 40%.
- Revised Summary Compensation Table includes previously omitted 2022 bonus amounts.
- Equity awards in 2022: Congleton $1.12M stock, Levy $483.5k stock, Rodman $492k options.

## SEC filing metadata
- accession: 0001933414-23-000024
- form_type: 8-K
- ticker: MLYS
- cik: 0001933414
- company_name: Mineralys Therapeutics, Inc.
- filed_at: 2023-03-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1933414/000193341423000024/0001933414-23-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1933414/000193341423000024/mlys202303178k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001933414-23-000024
- JSON: https://secwatch.observer/filing/0001933414-23-000024.json
- Plain text: https://secwatch.observer/filing/0001933414-23-000024.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.